Dublin, 30 May 2017: MSD, known as Merck in the U.S. and Canada, today announced that it will create 330 new jobs and invest €280 million over the next three years at two of its Irish manufacturing sites - important links in MSD’s global network of manufacturing plants. MSD maintains headquarters for the company and manufacturing division in the U.S.

The new jobs, which will be created in Carlow and Cork, are as a result of increased global demand for MSD’s medicines and vaccines produced in Ireland, while the investment will see both sites expand production facilities and capacity to meet that demand.

Read the full article here